Epilepsy biomarkers - Toward etiology and pathology specificity

Neurobiology of Disease
Asla PitkänenNoora Puhakka

Abstract

A biomarker is a characteristic that is measured as an indicator of normal biologic processes, pathogenic processes, or responses to an exposure or intervention, including therapeutic interventions. Biomarker modalities include molecular, histologic, radiographic, or physiologic characteristics. In 2015, the FDA-NIH Joint Leadership Council developed the BEST Resource (Biomarkers, EndpointS, and other Tools) to improve the understanding and use of biomarker terminology in biomedical research, clinical practice, and medical product development. The BEST biomarker categories include: (a) susceptibility/risk biomarkers, (b) diagnostic biomarkers, (c) monitoring biomarkers, (d) prognostic biomarkers, (e) predictive biomarkers, (f) pharmacodynamic/response biomarkers, and (g) safety biomarkers. Here we review 30 epilepsy biomarker studies that have identified (a) diagnostic biomarkers for epilepsy, epileptogenesis, epileptogenicity, drug-refractoriness, and status epilepticus - some of the epileptogenesis and epileptogenicity biomarkers can also be considered prognostic biomarkers for the development of epilepsy in subjects with a given brain insult, (b) predictive biomarkers for epilepsy surgery outcome, and (c) a response biomarke...Continue Reading

Citations

Oct 9, 2019·Epilepsia·Rachael GarnerDominique Duncan
Jan 16, 2020·Epilepsy Currents·Devin K BinderUNKNOWN AES/NINDS Epilepsy Benchmarks Stewards
Feb 6, 2020·The European Journal of Neuroscience·Esa R KorpiMatti Haltia
Mar 25, 2020·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Maria Elisa SerranoAlain Plenevaux
Jun 11, 2020·CNS Neuroscience & Therapeutics·Wenbiao XiaoLili Long
Nov 21, 2019·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·R Martins-FerreiraB Leal
Mar 20, 2020·Expert Review of Molecular Diagnostics·Sebastian BauerFelix Rosenow
Jan 11, 2019·International Journal of Molecular Sciences·Sandesh D ReddyDoodipala Samba Reddy
Mar 16, 2019·International Journal of Molecular Sciences·Jenni KarttunenAsla Pitkänen
Apr 16, 2019·Frontiers in Cellular Neuroscience·Xiaolin DengXiaohong Shi
May 24, 2020·Journal of Neurology·Surina Fordington, Mark Manford
Jun 12, 2020·International Journal of Molecular Sciences·Pascual Sanz, Maria Adelaida Garcia-Gimeno
Oct 21, 2020·Nature Reviews. Neurology·Rima Nabbout, Mathieu Kuchenbuch
Dec 10, 2020·Journal of Clinical Medicine·Emma KoehorstGisela Nogales-Gadea
Jul 10, 2019·Epilepsy & Behavior : E&B·Boulenouar MesraouaAli A Asadi-Pooya
Aug 20, 2019·Neuropharmacology·Gaetano TerroneAnnamaria Vezzani
Sep 10, 2019·Neuropharmacology·Pavel Klein, Ivana Tyrlikova
Nov 7, 2019·Epilepsy & Behavior : E&B·José Ramón BosqueDolores E López
Dec 4, 2020·Neuroscience and Biobehavioral Reviews·Monika I Roydeva, Antje A T S Reinders
Feb 3, 2021·Molecular and Cellular Biochemistry·Yifei YuGuangfan Chi
Jan 22, 2020·Neuropharmacology·Sergiusz JozwiakMartina Bebin
Feb 18, 2021·Nature Reviews. Neurology·Michele SimonatoKaren S Wilcox
Mar 17, 2021·Seizure : the Journal of the British Epilepsy Association·Estela M BruxelIscia Lopes-Cendes
Mar 25, 2021·Brain Communications·Francesca LovisariSilvia Zucchini
Jul 17, 2021·Epilepsia Open·Jacqueline A FrenchPaul Vespa
Oct 26, 2021·Human Cell·Jordan H WhitlockBrittany N Lasseigne

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Endosomes

Dysfunctional endosomal trafficking may be associated with Alzheimer’s disease (AD) pathology. Targeting the endosome may advance treatment options for AD. Here is the latest research on endosomes and AD.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Related Papers

Seminars in Neurology
P E Smith, Rhys Thomas
Neuropsihijatrija
J Ristić
British Medical Journal
J Turner
Experimental and Molecular Pathology
J H Kim
Proceedings of the Royal Society of Medicine
A E Russell
© 2022 Meta ULC. All rights reserved